MED vs SCI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Apr 29, 2026

MED

61.2
AI Score
VS
SCI Wins

SCI

64.5
AI Score

Investment Advisor Scores

MED

61score
Recommendation
BUY

SCI

65score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric MED SCI Winner
Forward P/E 12.4844 20.3666 MED
PEG Ratio 0.972 1.6961 MED
Revenue Growth -36.9% 1.7% SCI
Earnings Growth -87.2% 8.9% SCI
Tradestie Score 61.2/100 64.5/100 SCI
Profit Margin -4.8% 12.6% SCI
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, SCI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.